Former Stanford president, Marc Tessier-Lavigne, Ph.D., has been appointed as the new Chief Executive Officer of Xaira Therapeutics, a leading biotech company with a significant focus on AI in drug discovery.
Company Information
Company
Xaira Therapeutics
Location
Brisbane, California, United States
About
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease. The company seeks to rethink the drug discovery and development process from end-to-end by bringing together leading talent across three core areas: machine learning research to better understand biology, expansive data generation to power new models, and robust therapeutic product development to treat disease. Xaira is headquartered in the San Francisco Bay Area.
BrisbaneBiotechnologyArtificial IntelligenceTherapeuticsMachine Learning